Teva Pharmaceutical Industries | TEVA - Gross Profit On Sales

Stock Price
10,550.00
Daily Change
50.00 0.48%
Monthly
5.97%
Yearly
76.81%
Q1 Forecast
10,423.12

Teva Pharmaceutical Industries reported $2.66B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Guangzhou Baiy CNY 3.2B 157.18M Sep/2025
Jiangsu Hengrui CNY 6.36B 1.15B Sep/2025
Kalbe Farma IDR 3.45T 151.13B Sep/2025
Richter Gedeon HUF 143.37B 4.3B Sep/2025
Sh Fosun Pharma CNY 4.8B 93.72M Sep/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025